Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?

Ishwarlal Jialal, Sridevi Devaraj

Journal: Nutrition reviews 2005;63(8):290-3

PMID: 16190316

Full Text on Silverchair Information Systems View on PubMed

Abstract

Oxidative stress and inflammation play a crucial role in atherosclerosis. However, prospective clinical trials of dietary antioxidants with anti-inflammatory properties, such as alpha-tocopherol (AT), have not yielded positive results. AT supplementation decreases gamma-tocopherol (GT) levels. GT is an antioxidant with potent anti-inflammatory activity, and plasma GT levels are inversely associated with cardiovascular diseases. Thus, studies using pure GT, alone or in conjunction with AT, will elucidate its utility in cardiovascular disease prevention.

Address: Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology and Laboratory Medicine, University of California-Davis Medical Center, Sacramento, USA.

DOI: 10.1111/j.1753-4887.2005.tb00143.x

Link outs

Free resources

Medical:

https://medlineplus.gov/antioxidants.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-290

Subscription / membership required

Full Text Sources:

https://academic.oup.com/nutritionreviews/article-...

MeSH Terms: Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Arteriosclerosis, Biological Availability, Cardiovascular Diseases, Humans, Intestinal Absorption, Oxidative Stress, alpha-Tocopherol, gamma-Tocopherol